Podcasts about Diabetes Care

This issue will review: 1.     Real-World Prospective Validation and Economic Evaluation of Deep Learning-based Diabetic Retinopathy Detection from Fundus Photographs: A Systematic Review and Meta- Analysis 2.     Orforglipron, an oral small-molecule GLP-1 receptor agonist, for the treatment of obesity in people with type 2 diabetes (ATTAIN-2): a phase 3, double-blind, randomised, multicentre, placebo-controlled trial 3.     FDA removal of SI for GLP-1s – FDA Announcement Neil Read/John Comment 4.     Effectiveness and Safety of Statins in Type 2 Diabetes According to Baseline Cardiovascular Risk: A Target Trial Emulation Study 5.     GLP-1 Receptor Agonists and Risk of Optic Nerve or Vision-Threatening Events in Patients with Type 2 Diabetes or Cardiometabolic Diseases: A Meta-Analysis of Randomized Controlled Trials  Diabetes Core Update is a monthly podcast that presents and discusses the latest clinically relevant articles from the American Diabetes Association's four science and medical journals – Diabetes, Diabetes Care, Clinical Diabetes, and Diabetes Spectrum. Each episode is approximately 25 minutes long and presents 5-6 recently published articles from ADA journals. Intended for practicing physicians and health care professionals, Diabetes Core Update   discusses how the latest research and information published in journals of the American Diabetes Association are relevant to clinical practice and can be applied in a treatment setting. For more information about each of ADA's science and medical journals, please visit Diabetesjournals.org. Hosts: Neil Skolnik, M.D., Professor of Family and Community Medicine, Sidney Kimmel Medical College, Thomas Jefferson University; Associate Director, Family Medicine Residency Program, Abington Jefferson Health John J. Russell, M.D., Professor of Family and Community Medicine, Sidney Kimmel Medical College, Thomas Jefferson University; Chair-Department of Family Medicine, Abington Jefferson Health

Insulin resistance isn't just about sugar—and it's not just about weight.In this episode of Health Hacks, Tara Peterson and Dr. Jeni explain why resistance training is one of the most effective tools for improving insulin sensitivity and protecting metabolic health.Using current research and clinical insight, they break down how insulin works, why muscle is the body's largest glucose sink, and how strength training improves blood sugar control, reduces visceral fat, lowers inflammation, and slows metabolic aging—even after the workout is over.You'll also learn why up to 93% of U.S. adults are metabolically unhealthy, why muscle loss accelerates insulin resistance after age 30, and how just 2–3 strength training sessions per week can make a meaningful difference.If you're struggling with blood sugar swings, fatigue, inflammation, or stubborn weight gain—this episode is for you.

The session featured Dr. Sunil Gupta and Dr. Kavita Gupta, who provided detailed guidance on diabetes awareness, prevention, and long-term management. Dr. Sunil Gupta explained the historical significance of the discovery of insulin by Frederick Banting and highlighted how insulin transformed the lives of people with Type 1 diabetes. He stressed that type 2 diabetes is largely a lifestyle-related condition and warned that India is facing an epidemic, with nearly one in four adults (above 18 years age) are affected by diabetes or prediabetes, so called dysglycemia. He emphasised early screening, weight control, regular exercise, stress management, and avoidance of tobacco and alcohol to prevent complications such as heart disease, stroke, retinopathy, kidney failure, and limb amputations. Dr. Sunil Gupta also discussed the concepts of primary, secondary, and tertiary prevention, stating that many diabetes-related complications are preventable through timely intervention and awareness. He explained the differences between Type 1 and Type 2 diabetes, insulin resistance, and recent advances aimed at delaying the onset of Type 1 diabetes. Responding to audience queries, Dr. Kavita Gupta highlighted the importance of balanced nutrition in children and adolescents, regular meal timing, reduced screen time, and physical activity. She explained early warning signs of diabetes in children while answering one query she advised to stop using sugar, jaggery, or honey, as they all raise blood glucose levels. The programme concluded with a strong message that diabetes can be prevented and controlled through disciplined lifestyle choices, awareness, and community support. Expert- Dr Sunil Gupta & Dr Kavita Gupta Anchor- Purva Kulkarni Podcast: 14/11/2025 Recorded at: Akashwani Nagpur Episode: 104

In this special series on Metabolic-Dysfunction Associated Steatotic Liver Disease (MASLD) and Metabolic Dysfunction-associated steatohepatitis (MASH) our host, Dr. Neil Skolnik will discuss diagnosis and treatment of MASH using a case-based approach with two master clinicians, one a hepatologist and the other a primary care physician. This special episode is supported by an independent educational grant from Boehringer Ingelheim. Presented by: Neil Skolnik, M.D., Professor of Family and Community Medicine, Sidney Kimmel Medical College, Thomas Jefferson University; Associate Director, Family Medicine Residency Program, Abington Jefferson Health Alina M. Allen, M.D. Associate Professor of Medicine at Mayo Clinic in Rochester, Minnesota, where she serves as the Director of Hepatology and Director of the MASLD Clinic. Susan Kuchera, M.D. - Program Director of the Jefferson Health Abington Family Medicine Residency Program, Clinical Associate Professor of Family and Community Medicine in the Sidney Kimmel Medical College of Thomas Jefferson University Selected references: Metabolic Dysfunction–Associated Steatotic Liver Disease (MASLD) in People With Diabetes: The Need for Screening and Early Intervention. A Consensus Report of the American Diabetes Association. Diabetes Care 2025;48(7):1057–1082  

Superpowers for Good should not be considered investment advice. Seek counsel before making investment decisions. When you purchase an item, launch a campaign or create an investment account after clicking a link here, we may earn a fee. Engage to support our work.Watch the show on television by downloading the e360tv channel app to your Roku, LG or AmazonFireTV. You can also see it on YouTube.Devin: What is your superpower?Dr. Sahasranam: Emotional intelligence.Diabetes education saves lives, yet only 5 to 7 percent of people with diabetes ever receive it. This startling gap in care is the driving force behind My Diabetes Tutor, a telehealth platform founded by Dr. Prem Sahasranam. His mission? To make diabetes education accessible to everyone, regardless of geography or socioeconomic barriers.Dr. Sahasranam, a board-certified endocrinologist with nearly two decades of experience, explained how critical education is in diabetes management: “Studies have shown that just going through diabetes education reduces A1C by 0.73 points. At our program, our outcomes are two times better than the national average.” With over 9,000 patients served, My Diabetes Tutor consistently delivers remarkable results, achieving an average A1C reduction of 1.6 points—enough to significantly lower complications and mortality rates.The idea for My Diabetes Tutor was born out of necessity. Dr. Sahasranam shared a story about how two full-time diabetes educators in his rural California practice helped patients achieve exceptional outcomes. When they retired in 2018, he struggled to recruit replacements, a problem endemic to underserved areas. “I decided to build a telehealth program,” he said. “My goal was to solve an access issue and deliver diabetes education to people, irrespective of their zip code or language.”My Diabetes Tutor provides nationally accredited virtual diabetes education, covering medical nutrition therapy, continuous glucose monitoring, insulin pump training, and more. The platform recently launched the first-ever pediatric diabetes education program, a groundbreaking step toward addressing the needs of young patients.Dr. Sahasranam's vision extends beyond patient outcomes to include investor participation. My Diabetes Tutor is currently raising capital through a regulated crowdfunding campaign on StartEngine. “I want investors to own a piece of our growth and be part of our journey,” he said. The company generated over $2 million in revenue last year with a 61 percent gross margin, demonstrating both impact and financial viability.Dr. Sahasranam's work is not just about business; it's a mission to transform lives. By breaking down barriers to education, he's giving people the tools to manage their diabetes effectively, live healthier lives, and reduce complications.For those looking to make a difference—or simply to invest in a business delivering measurable impact—My Diabetes Tutor offers a unique opportunity.tl;dr:Dr. Prem Sahasranam founded My Diabetes Tutor to provide virtual education for diabetes management.The program addresses barriers to care in underserved communities by delivering telehealth services nationwide.My Diabetes Tutor achieves outcomes twice as effective as national averages in reducing A1C levels.The company generated over $2 million in 2025 and is raising capital via StartEngine crowdfunding.Prem credits emotional intelligence as his superpower, driving his mission to revolutionize diabetes care.How to Develop Emotional Intelligence As a SuperpowerDr. Prem describes his superpower as emotional intelligence, honed through years of experience as a board-certified endocrinologist. He explained, “Most health systems focus on the biology of the disease and fail to address the human part.” By understanding the emotional and practical needs of patients, Prem has created innovative solutions to improve access to diabetes education. He added, “I learned from my experience and built the right team, content, and technology to bring in diabetes education, easily accessible for patients.”Prem shared a pivotal story of a patient who had been struggling to control their diabetes despite receiving appropriate medications. The patient hesitated to make a two-hour drive to see Prem but eventually visited his practice and met with a diabetes educator. Without altering the patient's medications, the educator provided tailored guidance that helped the patient manage their condition. This experience inspired Prem to create My Diabetes Tutor, ensuring patients could access life-changing education from their own homes.Tips for Developing Emotional Intelligence:Reflect on past experiences to identify unmet needs and learn from them.Stay aware of the human challenges behind systemic issues.Focus on creating solutions that address both emotional and practical barriers.Build strong, empathetic teams that align with your mission.By following Dr. Prem's example and advice, you can make emotional intelligence a skill. With practice and effort, you could make it a superpower that enables you to do more good in the world.Remember, however, that research into success suggests that building on your own superpowers is more important than creating new ones or overcoming weaknesses. You do you!Get Your Copy!Guest ProfileDr. Prem Sahasranam (he/him):Founder, CEO, and Chief Medical Officer, My Diabetes Tutor (MDT)About My Diabetes Tutor (MDT): My Diabetes Tutor (MDT) is an ADCES-accredited telehealth service that provides comprehensive Diabetes Self-Management Education and Support (DSMES) via virtual, 1-on-1 sessions with Certified Diabetes Care and Education Specialists (CDCES). We bridge the gap for the 93% of eligible patients who currently do not utilize DSMES due to access barriers. We accept Medicare, Medicaid, and most private insurance (often with $0 out-of-pocket for patients). Participants achieve an average 1.6 pt reduction in A1C, 2x the national average for diabetes education.Website: mydiabetestutor.comCompany Facebook Page: facebook.com/mydiabetestutorInstagram Handle: @mydiabetestutor_Other URL: startengine.com/offering/my-diabetes-healthBiographical Information: Prem Sahasranam, MD (Dr. Sahas) is a Board-Certified Endocrinologist with over 20 years of clinical experience. He founded My Diabetes Tutor in 2019 to address the critical shortage of specialists in rural “care deserts”. A graduate of Madras Medical College with post-graduate training at Cornell University's Weill Medical College, he is currently an Assistant Clinical Professor at Loma Linda University and a dedicated advocate for health equity.LinkedIn Profile: linkedin.com/in/prem-sahasranam-ba10077Personal Facebook Profile: facebook.com/PremsahasranamThe Super Crowd, Inc., a public benefit corporation, is proud to have been named a finalist in the media category of the impact-focused, global Bold Awards.Support Our SponsorsOur generous sponsors make our work possible, serving impact investors, social entrepreneurs, community builders and diverse founders. Today's advertisers include rHealth, and Make Money with Impact Crowdfunding. Learn more about advertising with us here.Max-Impact Members(We're grateful for every one of these community champions who make this work possible.)Brian Christie, Brainsy | Cameron Neil, Lend For Good | Carol Fineagan, Independent Consultant | Hiten Sonpal, RISE Robotics | John Berlet, CORE Tax Deeds, LLC. | Justin Starbird, The Aebli Group | Lory Moore, Lory Moore Law | Mark Grimes, Networked Enterprise Development | Matthew Mead, Hempitecture | Michael Pratt, Qnetic | Mike Green, Envirosult | Nick Degnan, Unlimit Ventures | Dr. Nicole Paulk, Siren Biotechnology | Paul Lovejoy, Stakeholder Enterprise | Pearl Wright, Global Changemaker | Scott Thorpe, Philanthropist | Sharon Samjitsingh, Health Care Originals | Add Your Name HereUpcoming SuperCrowd Event CalendarIf a location is not noted, the events below are virtual.SuperCrowd Impact Member Networking Session: Impact (and, of course, Max-Impact) Members of the SuperCrowd are invited to a private networking session on February 17th at 1:30 PM ET/10:30 AM PT. Mark your calendar. We'll send private emails to Impact Members with registration details. Upgrade to Impact Membership today!SuperCrowdHour February: This month, Devin Thorpe will be digging deep into my core finance expertise to share guidance on projections and financial statements. We're calling it “Show Me the Numbers: Building Trust with Financial Clarity.” Register free to get all the details. February 18th at Noon ET/9:00 PT.Superpowers for Good Live Pitch: The top-raising Reg CF campaign of 2025 won the June 2025 Superpowers for Good Live Pitch. We're taking applications for the March 17, 2026, Live Pitch now. There is no fee to apply and no fee to pitch if selected! Apply here now!Community Event CalendarSuccessful Funding with Karl Dakin, Tuesdays at 10:00 AM ET - Click on Events.If you would like to submit an event for us to share with the 10,000+ changemakers, investors and entrepreneurs who are members of the SuperCrowd, click here.Manage the volume of emails you receive from us by clicking here.We use AI to help us write compelling recaps of each episode. Get full access to Superpowers for Good at www.superpowers4good.com/subscribe

Dr. Sunil Gupta spoke in detail about the growing link between obesity, diabetes, pregnancy-related risks, and modern lifestyle habits. He explained that obesity—particularly abdominal or visceral fat—is a major driver of Type 2 diabetes, heart disease, hypertension, and other metabolic complications. Dr. Gupta expressed that Indians are especially vulnerable due to a tendency toward central obesity even at lower body weight, making early screening through BMI and waist circumference measurements essential. Dr. Gupta highlighted that unhealthy dietary patterns, physical inactivity, excessive screen time, and high consumption of fast food and sugary beverages are key contributors to the rising burden of diabetes among children, adolescents, and young adults. He stressed that gestational diabetes and poor glucose control during pregnancy significantly increase the lifetime risk of diabetes for both the mother and the child. Breastfeeding, regular physical activity, post-delivery weight management, and long-term follow-up were emphasized as important protective measures. Addressing common myths, Dr. Gupta clarified that diabetes is not caused by sugar alone but by sustained excess calorie intake, insulin resistance, and genetic predisposition. He also strongly warned against tobacco use in any form, stating that it accelerates diabetes-related complications such as heart disease, kidney failure, stroke, and limb-threatening gangrene. The session concluded with a clear preventive message—eat less, walk more, sleep well, and smile (to reduce stress) Expert- Dr Sunil Gupta Anchor- Bhavana Lokhande Podcast: 23/01/2026 Recorded at: Akashwani Nagpur Episode: 103

Dr. Carol Johnston—Arizona State University nutrition professor and registered dietitian known online as “The Vinegar Lady”—joins Rob to break down what decades of research actually say about vinegar, blood glucose, and metabolic health. Johnston explains how her work began with an obscure 1988 rat study and led to a landmark 2004 Diabetes Care paper showing vinegar could blunt post-meal blood glucose spikes in people without diabetes, those with pre-diabetes, and those with type 2 diabetes. They dig into why vinegar still gets treated like “fringe” advice despite strong replication across countries—and why the mechanism overlaps with a major target of metformin. The conversation gets highly practical: why liquid vinegar matters (pills don't), how timing at the start of a meal changes outcomes, and the two core mechanisms—reduced starch digestion plus increased glucose uptake into muscle via GLUT4, similar to the effect of post-meal walking. Johnston also connects vinegar to the gut microbiome and acetate's growing role in brain and energy metabolism, sharing her own routine (on vegetables) and emerging findings on cognitive/depression measures supported by metabolomics. You'll also hear real-world implementations like homemade vinaigrettes (flip the ratio to 2:1 vinegar to oil), mustard as a stealth vinegar vehicle, and even “pickle sickles,” plus safety notes around dilution, enamel, and gastroparesis risk. Chapters: 00:01 Intro: “The Vinegar Lady” + why vinegar is on the table for diabetes 01:35 Johnston's background + why she studies simple, sustainable nutrition strategies 03:03 The 1988 rat study discovery → the first human trials with bagels + vinegar 04:32 Publishing in Diabetes Care (2004) + replication across the world 05:53 Why clinicians resist vinegar (“we have drugs for this”) + metformin overlap 10:28 Acetic acid, fermentation, and the gut microbiome connection (why it matters) 14:04 The two key mechanisms: starch digestion interference + faster muscle glucose uptake 22:46 Practical + safety: pills don't work, dilution, enamel/aspiration risk, timing with meals 25:53 Johnston's personal protocol + brain/cognition/depression angle + metabolomics support 46:47 Athletic applications: pickle juice, “pickle sickles,” mustard hack + where research goes next

Hey Diabuddy thank you for listening to show, send me some positive vibes with your favorite part of this episode.In this episode of The Healthy Diabetic Podcast, I sit down with Rachel Faber MS, RD, LDN, CDCES and Nicole Cordoba RN, CDCES, known online as CDE Diabuddies, to explore what diabetes care looks like when providers are also patients—and why pediatric diabetes care often feels worlds apart from adult care.Rachel and Nicole share their personal diagnosis stories—one diagnosed at age 4, the other at 17—and how those experiences shaped their paths into healthcare as Certified Diabetes Care and Education Specialists (CDCES). Together, they walk through what pediatric diabetes education which actually includes: multi-day hospital education, family involvement, hands-on insulin training, mental health screening, and structured follow-ups.The conversation dives deep into the systemic gaps that appear when patients transition into adult care, including shorter visits, less education, fewer resources, and limited emotional support. Ken and the guests discuss misdiagnosis, insurance barriers, Dexcom-induced anxiety, parental dynamics, and why flexibility—not rigidity—is key to long-term diabetes success.

How can AID close gaps in T2D care and help you personalize evidence-based AID for real-world practice? Credit available for this activity expires: 1/30/27 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/utilizing-automated-insulin-delivery-close-gaps-type-2-2026a10002xh?ecd=bdc_podcast_libsyn_mscpedu

Extreme cold exposure can have a significant impact on people with diabetes, especially those with long-standing disease and pre-existing vasculopathy. Dr. Gupta explained that vasoconstriction and vascular damage in people with diabetes can increase the risk of heart attack, stroke, and peripheral gangrene. He advised avoiding prolonged exposure to cold, maintaining body warmth, and seeking immediate medical care if warning symptoms appear. A major portion of the discussion centered on hypoglycemia (low blood sugar). Dr. Gupta noted that blood glucose levels below 70 mg/dL indicate hypoglycemia, while levels below 54 mg/dL can cause significant symptoms. He highlighted common causes, including long gaps between meals, prolonged action of insulin or certain oral medications like sulfonylureas, kidney dysfunction, and the use of some painkillers or antibiotics. The concept of hypoglycemia unawareness, caused by autonomic neuropathy, was explained as a dangerous condition in which warning symptoms may be absent. Dr. Rakesh Parikh (Jaipur) added that wide glucose fluctuations and long duration of diabetes increase the risk of autonomic dysfunction. He emphasized the role of Continuous Glucose Monitoring (CGM) devices in identifying unnoticed low-sugar episodes and preventing serious complications. He also reinforced the need for regular screening of target organs—eyes, kidneys, nerves, heart, and cholesterol—especially in people with long-standing diabetes. Expert- Dr Sunil Gupta & Dr Rakesh Parikh (Jaipur) Anchor- Swati Huddar Podcast: 09/01/2026 Recorded at: Akashwani Nagpur

This issue will review: 1.     Semaglutide and cardiovascular outcomes by baseline and changes in adiposity measurements: a prespecified analysis of the SELECT trial 2.     Impact of Oral Semaglutide on Kidney Outcomes in People with Type 2 Diabetes: Results from the SOUL Randomized Trial 3.     The effect of substituting water for artificially sweetened beverages on glycemic and weight measures in people with type 2 diabetes: The Study of Drinks with Artificial Sweeteners (SODAS), a randomized trial 4.     Effects of carbohydrate-restricted diets and macronutrient replacements on cardiovascular health and body composition in adults: a meta-analysis of randomized trials Trial Diabetes Core Update is a monthly podcast that presents and discusses the latest clinically relevant articles from the American Diabetes Association's four science and medical journals – Diabetes, Diabetes Care, Clinical Diabetes, and Diabetes Spectrum. Each episode is approximately 25 minutes long and presents 5-6 recently published articles from ADA journals. Intended for practicing physicians and health care professionals, Diabetes Core Update   discusses how the latest research and information published in journals of the American Diabetes Association are relevant to clinical practice and can be applied in a treatment setting. For more information about each of ADA's science and medical journals, please visit Diabetesjournals.org. Hosts: Neil Skolnik, M.D., Professor of Family and Community Medicine, Sidney Kimmel Medical College, Thomas Jefferson University; Associate Director, Family Medicine Residency Program, Abington Jefferson Health John J. Russell, M.D., Professor of Family and Community Medicine, Sidney Kimmel Medical College, Thomas Jefferson University; Chair-Department of Family Medicine, Abington Jefferson Health

In this AIR-Vividhbharti live phone-in program, Dr. Sunil Gupta focused on the growing diabetes epidemic in India and emphasized the urgent need for early prevention and screening. He highlighted that diabetes is increasingly being diagnosed at a younger age due to sedentary lifestyles, unhealthy dietary habits, stress, and genetic predisposition. Dr. Gupta pointed out that diabetes often remains silent in its early stages and is frequently detected only after complications have developed. He advised regular screening after the age of 30–35 years, early recognition of warning symptoms such as excessive thirst, frequent urination, fatigue, and vision changes, along with strict control of blood sugar, blood pressure, and cholesterol to prevent long-term complications. He further clarified that diabetes “reversal” should be understood as remission, which can be achieved through sustained lifestyle modification, weight management, regular physical activity, and appropriate medical treatment. Dr. Kavita Gupta, a nutrition and lifestyle expert, addressed practical dietary strategies for diabetes prevention and control, particularly during festive and social occasions. She stressed that moderation, rather than deprivation, is the cornerstone of healthy eating. Dr. Kavita Gupta recommended beginning meals with fiber-rich foods such as salads and vegetables, followed by adequate protein intake then Carbohydrate to help stabilize blood sugar levels. Podcast- 26/12/2025 Anchor- Mrs. Kalyani Gokhale Expert- Dr Sunil Gupta & Dr Kavita Gupta

For some people, diabetes can be very hard to control, even with the standard glucose-lowering therapies. Several studies have demonstrated that endogenous hypercortisolism is prevalent among these individuals. What’s the relationship between type 2 diabetes and hypercortisolism, and what do health care providers need to know about that relationship? To help answer those questions, host Aaron Lohr talks with two guests. Vivian A. Fonseca, MD, is a professor of medicine, assistant dean for clinical research, the Tullis-Tulane Alumni Chair in Diabetes, and chief of the section of endocrinology at Tulane University Medical Center in New Orleans. James W. Findling, MD, is a professor of medicine and surgery at the Medical College of Wisconsin. Drs. Fonseca and Findling are authors of an article published in the journal Diabetes Care looking at the CATALYST study: “Inadequately Controlled Type 2 Diabetes and Hypercortisolism: Improved Glycemia With Mifepristone Treatment.” This episode is made possible by support from Corcept Therapeutics Inc. Show notes are available at https://www.endocrine.org/podcast/enp110 — for helpful links or to hear more podcast episodes, visit https://www.endocrine.org/podcast

The American Diabetes Association's 2026 Standards of Care in Diabetes are here! Let's talk about what's changed and how to better care for our older adults living with diabetes. 2026 Standards of Care in Diabetes:  https://diabetesjournals.org/care/issue/49/Supplement_1 Tamara Ruggles, PharmD, BCGP, FASCP:  www.linkedin.com/in/tamara-ruggles-491882251 Diana Isaacs, PharmD, BCPS, BCACP, BC-ADM, CDCES:  https://www.linkedin.com/in/diana-isaacs-pharmd-bcps-bcacp-bc-adm-cdces-45803426/  

This issue will review: 1.     Evolocumab in Patients without a Previous Myocardial Infarction or Stroke 2.     SGLT2 Inhibitors and Kidney Outcomes by Glomerular Filtration Rate and Albuminuria 3.     Continuous SGLT-2, GLIP-1RA and Frailty Progression in Older Adults with Type 2 Diabetes   4.     Effects of Sodium Glucose Cotransporter 2 Inhibitors by Diabetes Status and Level of Albuminuria 5.     Tirzepatide in Adults With Type 1 Diabetes: A Phase 2 Randomized Placebo-Controlled Clinical Trial 6.     Listening to Hypoglycemia: Voice as a Biomarker for Detection of a Medical Emergency Using Machine Learning Diabetes Core Update is a monthly podcast that presents and discusses the latest clinically relevant articles from the American Diabetes Association's four science and medical journals – Diabetes, Diabetes Care, Clinical Diabetes, and Diabetes Spectrum. Each episode is approximately 25 minutes long and presents 5-6 recently published articles from ADA journals. Intended for practicing physicians and health care professionals, Diabetes Core Update   discusses how the latest research and information published in journals of the American Diabetes Association are relevant to clinical practice and can be applied in a treatment setting. For more information about each of ADA's science and medical journals, please visit Diabetesjournals.org. Hosts: Neil Skolnik, M.D., Professor of Family and Community Medicine, Sidney Kimmel Medical College, Thomas Jefferson University; Associate Director, Family Medicine Residency Program, Abington Jefferson Health John J. Russell, M.D., Professor of Family and Community Medicine, Sidney Kimmel Medical College, Thomas Jefferson University; Chair-Department of Family Medicine, Abington Jefferson Health

Dr. Sunil Gupta emphasized that World Diabetes Day, celebrated on November 14, marks the birthday of Frederick Banting, who discovered insulin. Today, it is not limited to a single day but observed throughout November as a month of awareness activities. Among the elderly, diabetes often coexists with complications like high risk of hypoglycemia, associated neuropathy, and other health issues, making regular monitoring, proper medication, hydration, and adequate sleep is essential. Diabetic neuropathy, which causes tingling or numbness in the feet, results from nerve damage but can be reversible in the early stages through good sugar control, exercise and timely check-ups. While answering the query he advised that diabetes should not be hidden—informing friends or colleagues ensures timely help during a low-sugar episode. Insulin remains a lifeline for Type1 diabetes, and over time, many with Type 2 diabetes may also require it. Dr. Kavita Gupta highlighted that stress hormones like cortisol and adrenaline can raise blood sugar levels. Thus, making meditation, positive thinking, and balanced routines is vital. During festivals, healthier options such as fruit baskets or nuts can replace sweets. She added that people with prediabetes should begin focusing on diet, weight, and exercise now to help prevent a future diabetes epidemic. Expert- Dr Sunil Gupta & Dr Kavita Gupta Anchor- Mrs. Kalyani Gokhale Podcast: 31/10/2025 Recorded at: Akashwani Nagpur     Episode: 98

Dr. Sunil Gupta highlighted that insulin remains the most effective and life-saving treatment for diabetes, especially when oral medications fail. He explained that many people with Type 2 diabetes eventually require insulin, and delaying its initiation can lead to serious complications such as neuropathy, retinopathy, kidney disease, heart disease and diabetic foot problems. Addressing common fears, he clarified that modern insulin pens are almost painless and newer insulin analogues closely mimic natural insulin action, significantly reducing the risk of hypoglycaemia, particularly at night. He stressed the importance of regular blood sugar monitoring, HbA1c testing and annual health check-ups after 30 years of age, noting that many individuals with diabetes may remain asymptomatic. He also drew attention to insulin-requiring diabetes in undernourished adults in India and the need for timely specialist referral. Kavita Gupta emphasized healthy dietary practices, explaining why whole fruits are better than fruit juices due to fiber and lower glycaemic index. She advised consuming low-GI foods and shared practical tips to prevent hypoglycaemia through timely meals and planned nutrition, especially for children, the elderly, and physically active individuals. Expert- Dr Sunil Gupta & Dr Kavita Gupta Anchor- Mrs. Shraddha Bharadwaj Podcast: 10/05/2019 Recorded at: Akashwani Nagpur     Episode: 99

Dr. Sunil Gupta explained the complications of diabetes in simple and easily understandable language, highlighting the serious consequences of long-term uncontrolled blood sugar. He stated that persistent hyperglycaemia leads to microvascular complications such as diabetic neuropathy, retinopathy, and nephropathy, while major events like heart attack, stroke, and gangrene are associated with diseases of the large blood vessels. He described early symptoms of diabetic neuropathy, including burning sensation, numbness, tingling, and pain in the feet, and urged patients not to ignore these warning signs. Dr. Gupta clearly emphasized that diabetes control cannot be achieved by medicines alone. He stressed the importance of regular monitoring of blood glucose, HbA1c, blood pressure, cholesterol, and vitamin levels, along with avoiding wide fluctuations in blood sugar levels. He described insulin as the safest and most effective treatment for diabetes and cautioned that unnecessary delay in initiating insulin therapy can significantly increase the risk of complications. He also emphasized that before managing gangrene or planning surgery, strict control of blood sugar, blood pressure, and cholesterol, along with regular walking, quitting smoking and tobacco use, avoiding alcohol, and maintaining a disciplined lifestyle, are extremely important to improve outcomes and prevent limb loss. Expert- Dr Sunil Gupta Anchor- Mrs. Purva Kulkarni Podcast: 12/12/2025 Recorded at: Akashwani Nagpur     Episode:100

In this Christmas Eve episode, Jess and Wendy chat with dietitian Krystal Martinez to debunk a major diabetes myth: that you have to give up your cultural foods to manage blood sugar. Krystal, a first-generation Mexican-American specializing in prediabetes and type 2 diabetes, shares why staples like tortillas, rice, and beans belong on your plate. She offers practical tips for balancing meals during the holidays and beyond, covering portions, protein, fiber, and healthy fats. We also go into the white vs. brown rice debate, the harm of cutting out entire food groups, and how to enjoy Nochebuena without guilt. Happy Holidays!If you're living with diabetes or prediabetes and want personalized support from a Registered Dietitian Nutritionist covered by insurance, visit diabetesdigital.co to connect with our culturally aware and weight-inclusive team. And if you love the show, don't forget to rate and review us on iTunes or Spotify—it makes a huge difference! For additional resources and show notes, head to diabetesdigital.co/podcast.

In this episode, we sit down with Sarah Hormachea, MS, RD, CDCES, BC-ADM, a Diabetes Care and Education Specialist whose work spans national guideline committees, tribal community health, and clinical practice. Sarah breaks down how medical nutrition therapy (MNT) for type 1 diabetes has transformed—moving away from rigid, prescriptive diet rules and toward individualized, culturally inclusive care.She shares what's changed in the latest nutrition guidelines, how technology and real-time glucose insights are reshaping patient conversations, and what the first year after diagnosis really looks like for many people. Sarah also dives into emerging research, from plant-forward approaches to ketogenic patterns, gut health, and medication advances that could influence nutrition strategies in the years ahead.Listeners will also learn where to find reliable resources, how to stay connected with the latest developments, and how to access Sarah's work and insights.Sarah Hormachea is a Diabetes Care and Education Specialist who believes nutrition therapy should honor both culture and science. Drawing on 10+ years in clinical and community settings, she helps make diabetes care more personal, inclusive, and effective.“Sometimes it takes these diagnoses for people to stop and reflect and recognize that health is wealth, right? And if you have, if you don't have your health - what do you have?”Question of the Day:How has nutrition played a role in how you (or a loved one) manages or navigates type 1 diabetes? On This Episode You Will Learn:How Diabetes Care and Education Specialists (DCES) support people with type 1 diabetes at every stage of care.The most important updates from recent medical nutrition therapy guidelines—and why they matter.What early nutrition support looks like immediately after diagnosis and during the first year.Common nutrition myths in type 1 diabetes and how to approach them with evidence and compassion.The research and trends poised to shape the future of type 1 diabetes nutrition care.Connect with Yumlish!Yumlish Website: YumlishYumlish on Instagram: @yumlish_Yumlish on Facebook: YumlishYumlish on Twitter: @yumlish_Yumlish on LinkedIn: YumlishConnect with Sarah Hormachea!Website URL: www.sarahhormachea.com Instagram URL: https://www.instagram.com/sarah.hormachea/ Facebook URL: https://www.facebook.com/sarahhormachea.diabetescare LinkedIn URL: https://www.linkedin.com/in/sarahhormachea/ 

Chegou o episódio escolhido por vocês! Marcela Belleza e Joanne Alves convidam Carol Millon para conversar sobe 6 clinicagens de inibidores de SGLT2, as gliflozinas:Indicações além do DMRisco de CAD euglicêmicaQuando não usar?⁠Cuidados com doença aguda (sick day) e hipovolemia⁠Cuidados pré-operatórioRisco de fratura e amputaçãoReferências:1. Bailey CJ, et al. Dapagliflozin add-on to metformin in type 2 diabetes inadequately controlled with metformin: a randomized, double-blind, placebo-controlled 102-week trial. BMC Med. 2013;11:43. Published 2013 Feb 20. doi:10.1186/1741-7015-11-432. Bersoff-Matcha SJ, et al. Fournier Gangrene Associated With Sodium-Glucose Cotransporter-2 Inhibitors: A Review of Spontaneous Postmarketing Cases. Ann Intern Med. 2019;170(11):764-769. doi:10.7326/M19-00853. Chang HY, et al. Association Between Sodium-Glucose Cotransporter 2 Inhibitors and Lower Extremity Amputation Among Patients With Type 2 Diabetes. JAMA Intern Med. 2018;178(9):1190-1198. doi:10.1001/jamainternmed.2018.3034 4. Clar C, et al. Systematic review of SGLT2 receptor inhibitors in dual or triple therapy in type 2 diabetes. BMJ Open. 2012 Oct 18;2(5):e001007. doi: 10.1136/bmjopen-2012-001007. PMID: 23087012; PMCID: PMC3488745.5. Das SR, et al. 2020 Expert Consensus Decision Pathway on Novel Therapies for Cardiovascular Risk Reduction in Patients With Type 2 Diabetes: A Report of the American College of Cardiology Solution Set Oversight Committee. J Am Coll Cardiol. 2020 Sep 1;76(9):1117-1145. doi: 10.1016/j.jacc.2020.05.037. Epub 2020 Aug 5. PMID: 32771263; PMCID: PMC7545583. 6. Fralick M, et al. Risk of amputation with canagliflozin across categories of age and cardiovascular risk in three US nationwide databases: cohort study. BMJ. 2020;370:m2812. Published 2020 Aug 25. doi:10.1136/bmj.m28127. Li D, et al. Urinary tract and genital infections in patients with type 2 diabetes treated with sodium-glucose co-transporter 2 inhibitors: A meta-analysis of randomized controlled trials. Diabetes Obes Metab. 2017;19(3):348-355. doi:10.1111/dom.128258. Neal B, et al. Rationale, design, and baseline characteristics of the Canagliflozin Cardiovascular Assessment Study (CANVAS)--a randomized placebo-controlled trial. Am Heart J. 2013;166(2):217-223.e11. doi:10.1016/j.ahj.2013.05.0079. Nyirjesy P, et al. Evaluation of vulvovaginal symptoms and Candida colonization in women with type 2 diabetes mellitus treated with canagliflozin, a sodium glucose co-transporter 2 inhibitor. Curr Med Res Opin. 2012;28(7):1173-1178. doi:10.1185/03007995.2012.69705310. Perkovic V, et al. Canagliflozin and Renal Outcomes in Type 2 Diabetes and Nephropathy. N Engl J Med. 2019;380(24):2295-2306. doi:10.1056/NEJMoa181174411. Rosenwasser RF, et al. SGLT-2 inhibitors and their potential in the treatment of diabetes. Diabetes Metab Syndr Obes. 2013 Nov 27;6:453-67. doi: 10.2147/DMSO.S34416. PMID: 24348059; PMCID: PMC3848644.12. Sridharan K, Sivaramakrishnan G. Risk of limb amputation and bone fractures with sodium glucose cotransporter-2 inhibitors: a network meta-analysis and meta-regression. Expert Opin Drug Saf. 2025;24(7):797-804. doi:10.1080/14740338.2024.237775513. Ueda P,  et al. Sodium glucose cotransporter 2 inhibitors and risk of serious adverse events: nationwide register based cohort study. BMJ. 2018;363:k4365. Published 2018 Nov 14. doi:10.1136/bmj.k436514. Watts NB, et al. Effects of Canagliflozin on Fracture Risk in Patients With Type 2 Diabetes Mellitus. J Clin Endocrinol Metab. 2016 Jan;101(1):157-66. doi: 10.1210/jc.2015-3167. Epub 2015 Nov 18. PMID: 26580237; PMCID: PMC4701850.15. Zhuo M, et al. Association of Sodium-Glucose Cotransporter-2 Inhibitors With Fracture Risk in Older Adults With Type 2 Diabetes. JAMA Netw Open. 2021;4(10):e2130762. Published 2021 Oct 1. doi:10.1001/jamanetworkopen.2021.3076216. Emerson Cestari Marino, Leandra Anália Freitas Negretto, Rogério Silicani Ribeiro, Denise Momesso, Alina Coutinho Rodrigues Feitosa, Marcos Tadashi Kakitani Toyoshima, Joaquim Custódio da Silva Junior, Sérgio Vencio, Marcio Weissheimer Lauria, João Roberto de Sá, Domingos A. Malerbi, Fernando Valente, Silmara A. O. Leite, Danillo Ewerton Oliveira Amaral, Gabriel Magalhães Nunes Guimarães, Plínio da Cunha Leal, Maristela Bueno Lopes, Luiz Carlos Bastos Salles, Liana Maria Torres de Araújo Azi, Amanda Gomes Fonseca, Lorena Ibiapina M. Carvalho, Francília Faloni Coelho, Bruno Halpern, Cynthia M. Valerio, Fabio R. Trujilho,  Antonio Carlos Aguiar Brandão, Ruy Lyra e Marcello Bertoluci. Rastreamento e Controle da Hiperglicemia no Perioperatório – Posicionamento Conjunto da Sociedade Brasileira de Diabetes (SBD), Sociedade Brasileira de Anestesiologia (SBA) e Associação Brasileira para o Estudo da Obesidade e Síndrome Metabólica (ABESO). Diretriz Oficial da Sociedade Brasileira de Diabetes (2025). DOI: 10.29327/5660187.2025-10 , ISBN: 978-65-5941-367-6.17. Singh LG, Ntelis S, Siddiqui T, Seliger SL, Sorkin JD, Spanakis EK. Association of Continued Use of SGLT2 Inhibitors From the Ambulatory to Inpatient Setting With Hospital Outcomes in Patients With Diabetes: A Nationwide Cohort Study. Diabetes Care. 2024;47(6):933-940. doi:10.2337/dc23-112918. Mehta PB, Robinson A, Burkhardt D, Rushakoff RJ. Inpatient Perioperative Euglycemic Diabetic Ketoacidosis Due to Sodium-Glucose Cotransporter-2 Inhibitors - Lessons From a Case Series and Strategies to Decrease Incidence. Endocr Pract. 2022;28(9):884-888. doi:10.1016/j.eprac.2022.06.00619. Umapathysivam MM, Morgan B, Inglis JM, et al. SGLT2 Inhibitor-Associated Ketoacidosis vs Type 1 Diabetes-Associated Ketoacidosis. JAMA Netw Open. 2024;7(3):e242744. Published 2024 Mar 4. doi:10.1001/jamanetworkopen.2024.274420. Fleming N, Hamblin PS, Story D, Ekinci EI. Evolving Evidence of Diabetic Ketoacidosis in Patients Taking Sodium-Glucose Cotransporter 2 Inhibitors. J Clin Endocrinol Metab. 2020;105(8):dgaa200. doi:10.1210/clinem/dgaa20021. Neuen BL, Young T, Heerspink HJL, et al. SGLT2 inhibitors for the prevention of kidney failure in patients with type 2 diabetes: a systematic review and meta-analysis. Lancet Diabetes Endocrinol. 2019;7(11):845-854. doi:10.1016/S2213-8587(19)30256-622. Braunwald E. Gliflozins in the Management of Cardiovascular Disease. N Engl J Med. 2022;386(21):2024-2034. doi:10.1056/NEJMra211501123. Zinman B, Wanner C, Lachin JM, et al. Empagliflozin, Cardiovascular Outcomes, and Mortality in Type 2 Diabetes. N Engl J Med. 2015;373(22):2117-2128. doi:10.1056/NEJMoa150472024. Neal B, Perkovic V, Mahaffey KW, et al. Canagliflozin and Cardiovascular and Renal Events in Type 2 Diabetes. N Engl J Med. 2017;377(7):644-657. doi:10.1056/NEJMoa161192525. Wiviott SD, Raz I, Bonaca MP, et al. Dapagliflozin and Cardiovascular Outcomes in Type 2 Diabetes. N Engl J Med. 2019;380(4):347-357. doi:10.1056/NEJMoa181238926. McMurray JJV, Solomon SD, Inzucchi SE, et al. Dapagliflozin in Patients with Heart Failure and Reduced Ejection Fraction. N Engl J Med. 2019;381(21):1995-2008. doi:10.1056/NEJMoa191130327. Packer M, Anker SD, Butler J, et al. Cardiovascular and Renal Outcomes with Empagliflozin in Heart Failure. N Engl J Med. 2020;383(15):1413-1424. doi:10.1056/NEJMoa202219028. Anker SD, Butler J, Filippatos G, et al. Empagliflozin in Heart Failure with a Preserved Ejection Fraction. N Engl J Med. 2021;385(16):1451-1461. doi:10.1056/NEJMoa210703829. Heerspink HJL, Stefánsson BV, Correa-Rotter R, et al. Dapagliflozin in Patients with Chronic Kidney Disease. N Engl J Med. 2020;383(15):1436-1446. doi:10.1056/NEJMoa202481630. The EMPA-KIDNEY Collaborative Group, Herrington WG, Staplin N, et al. Empagliflozin in...

Coming to you from the #NCPA2025 expo floor, host John Beckner and co-host Ed Cohen talk with Brian Connelly, president and CEO of TheracosBio, about Brenzavvy (bexagliflozin), an FDA-approved oral SGLT2 inhibitor for adults with Type 2 diabetes. They discuss how the company's model bypasses PBMs to offer pharmacists and patients a fair, transparent price.

In this special series on Metabolic-Dysfunction Associated Steatotic Liver Disease (MASLD) and Metabolic Dysfunction-associated steatohepatitis (MASH) our host, Dr. Neil Skolnik will discuss Epidemiology, Importance, Screening, Diagnosis and Treatment of MASH. This special episode is supported by an independent educational grant from Boehringer Ingelheim. Presented by: Neil Skolnik, M.D., Professor of Family and Community Medicine, Sidney Kimmel Medical College, Thomas Jefferson University; Associate Director, Family Medicine Residency Program, Abington Jefferson Health Alina M. Allen, M.D. Associate Professor of Medicine at Mayo Clinic in Rochester, Minnesota, where she serves as the Director of Hepatology and Director of the MASLD Clinic. Selected references: Metabolic Dysfunction–Associated Steatotic Liver Disease (MASLD) in People With Diabetes: The Need for Screening and Early Intervention. A Consensus Report of the American Diabetes Association. Diabetes Care 2025;48(7):1057–1082

Dr. Sunil Gupta addressed several common diabetes-related myths—especially those that spread during festivals—such as the false belief that diabetes spreads through touch, that bitter gourd juice is a cure, or that eating sweets directly causes diabetes. He clarified that such misconceptions can misguide people and delay proper care. Dr. Gupta explained that tingling or numbness in the hands and feet is not always due to high sugar levels; it can also be caused by nerve pressure, sitting posture, or Vitamin B12 deficiency. In Type 2 diabetes, medicines may reduce with disciplined lifestyle changes, but complete cure is rare. Diabetes may get “reversed” in specific situations such as gestational diabetes after delivery, stress-induced diabetes, or after bariatric surgery. He also highlighted that children's late-night gaming habits harm mental health and sometimes require psychological guidance. Dr. Gupta discussed the stages of Diabetic Retinopathy, noting that retinal damage cannot be reversed, though progression can be slowed with timely treatment. Conditions like Vitamin D3/B12 deficiency, infections, high BP, or glaucoma can also affect vision—so both diabetes and eye specialists should be consulted. Dr. Gupta emphasized that diabetes is a lifestyle condition and individuals should not be labeled as “patients.” Expert- Dr Sunil Gupta   Anchor- Mrs. Shraddha Bharadwaj     Podcast: 11/10/2019 Recorded at: Akashwani Nagpur 

Scott and Jenny discuss bolusing for Sonic Tater Tots Go tubeless with Omnipod 5 or Omnipod DASH * Dexcom G7 CONTOUR NextGen smart meter and CONTOUR DIABETES app Get your supplies from US MED  or call 888-721-1514 Tandem Mobi  twiist AID System Free Juicebox Community (non Facebook) Type 1 Diabetes Pro Tips - THE PODCAST Eversense CGM Medtronic Diabetes Drink AG1.com/Juicebox Touched By Type 1 Take the T1DExchange survey Use code JUICEBOX to save 40% at Cozy Earth  Apple Podcasts> Subscribe to the podcast today! The podcast is available on Spotify, Google Play, iHeartRadio, Radio Public, Amazon Music and all Android devices The Juicebox Podcast is a free show, but if you'd like to support the podcast directly, you can make a gift here or buy me a coffee. Thank you! The Pod has an IP28 rating for up to 25 feet for 60 minutes. The PDM is not waterproof. Brown et al. Diabetes Care (2021). Sherr et al. Diabetes Care (2022). Pasquel FJ, et al. JAMA Network Open (2025). Single-arm studies comparing 3 months of Omnipod 5 use to standard therapy in 240 people aged 6-70 years and 80 people aged 2-5.9 years with type 1 diabetes and 305 people aged 18-75 years with type 2 diabetes. Disclaimer - Nothing you hear on the Juicebox Podcast or read on Arden's Day is intended as medical advice. You should always consult a physician before making changes to your health plan.  If the podcast has helped you to live better with type 1 please tell someone else how to find it!  

Throughout the session, Dr. Sunil Gupta shared practical and easy-to-follow advice on managing diabetes effectively in daily life. He emphasized the importance of moderation during festivals, advising people to enjoy the “sweetness of words” rather than consuming excessive sweets. A positive attitude, self-discipline, and mindful choices, he said, are crucial for maintaining good health. Dr. Gupta encouraged individuals with diabetes to monitor their blood sugar regularly using a glucometer or continuous glucose monitoring (CGM) system to understand their glucose trends and make timely adjustments in diet, medication, and physical activity. Highlighting that 50–70% of people with diabetes are overweight, he explained the “Fit Fat Concept,” which means that even if a person carries extra weight, staying active and physically fit can significantly reduce diabetes-related risks. He also recommended avoiding HFSS foods (High Fat, High Salt, and High Sugar) and instead including more fiber-rich foods, vegetables, and fruits in the daily diet. Stressing the importance of consistent exercise, proper hydration, and stress control, Dr. Gupta concluded that diabetes management goes beyond medicines — it requires awareness, lifestyle balance, and a positive mindset for long-term well-being. Expert- Dr Sunil Gupta   Anchor- Mrs. Shraddha Bharadwaj     Podcast: 25/10/2019 Recorded at: Akashwani Nagpur     Episode: 96

Dr. Sunil Gupta shared key insights for diabetes patients. Diabetes affects not just the pancreas but blood vessels throughout the body, with the liver being particularly vulnerable. Hyperinsulinemia (excess insulin) and long-term high blood sugar, high cholesterol, and high triglycerides can lead to fatty liver, which may progress to fibrosis or cirrhosis of liver. Dr. Gupta emphasized that human insulin is safe and effective, while insulin analogs (ultra-fast and ultra-long) are more physiologically aligned with the body's needs. Doses should be adjusted based on weight. Every person with diabetes should have a glucometer, as frequent monitoring helps control sugar levels and adjust doses. Diet and lifestyle play a crucial role. Limit sugar, jaggery, sweets, and honey, and prefer brown rice for its lower glycemic index. Exercise, weight management, and controlling blood pressure and cholesterol are essential. Foot care, eye check-ups, and avoiding alcohol, smoking, and tobacco are vital. For children with Type 1 diabetes, parent training, workshops, and insulin learning programs ensure safe management and prevent complications. Expert- Dr Sunil Gupta   Anchor- Mrs. Shraddha Bharadwaj     Podcast: 14/06/2019    Recorded at: Akashwani Nagpur     Episode: 94

We're looking at some major policy issues happening in Washington, and what you can really do to effect change. George Huntley is the CEO of DPAC, the Diabetes Patient Advocacy Coalition. We've got a lot to cover: Medicare changes like competitive bidding that could dramatically limit access to CGMs and insulin pumps for seniors, the changing landscape around GLP 1 meds, and we talk about patient advocacy wins. I know some of you are cynical, but it can work. If you've ever thought your voice doesn't matter, this conversation may change your mind. This podcast is not intended as medical advice. If you have those kinds of questions, please contact your health care provider. Announcing Community Commericals! Learn how to get your message on the show here. Learn more about studies and research at Thrivable here Please visit our Sponsors & Partners - they help make the show possible! Learn more about Gvoke Glucagon Gvoke HypoPen® (glucagon injection): Glucagon Injection For Very Low Blood Sugar (gvokeglucagon.com) Omnipod - Simplify Life Learn about Dexcom  Check out VIVI Cap to protect your insulin from extreme temperatures The best way to keep up with Stacey and the show is by signing up for our weekly newsletter: Sign up for our newsletter here Here's where to find us: Facebook (Group) Facebook (Page) Instagram Check out Stacey's books! Learn more about everything at our home page www.diabetes-connections.com  Reach out with questions or comments: info@diabetes-connections. Keywords Diabetes, D-PAC, Medicare, GLP-1 medications, patient advocacy, healthcare access, insulin pumps, CGMs, diabetes technology, legislative reform AI info below: Summary In this conversation, George Huntley, CEO of the Diabetes Patient Advocacy Coalition (D-PAC), discusses the critical role of advocacy in improving diabetes care and access to technology. He highlights the challenges faced by patients, particularly regarding Medicare coverage for insulin pumps and continuous glucose monitors (CGMs), and the implications of recent legislative changes. The discussion also covers the potential of GLP-1 medications in diabetes management and the importance of patient stories in advocacy efforts. Takeaways D-PAC focuses on affordable and equitable access to diabetes care. Advocacy is crucial for influencing healthcare policies. Competitive bidding for diabetes technology could limit access for seniors. Patient stories are essential in legislative advocacy. GLP-1 medications show promise in reshaping diabetes treatment. Economic factors play a significant role in healthcare access. The aging population of type 1 diabetes patients requires urgent attention. Collaboration among advocacy groups is vital for success. Healthcare costs are driven more by major medical expenses than by drug prices. Continued advocacy is necessary to protect patient access to care. Chapters 00:00 Introduction to Diabetes Advocacy 03:01 The Role of D-PAC in Diabetes Care 05:53 Challenges in Medicare Coverage for Diabetes Technology 09:11 The Impact of Competitive Bidding on Seniors 11:55 Advocacy Efforts and Legislative Challenges 14:57 The Future of GLP-1 Medications 17:56 Economic Implications of Diabetes Management 21:01 The Importance of Patient Advocacy 23:59 Healthcare Costs and Insurance Dynamics 26:56 The Need for Continued Advocacy 29:54 Conclusion and Call to Action

Listen to our radio program first aired on SBS South Asian on Tuesday, 2 December 2025 at 2 PM, focusing on weekly Australian news, Australian PM's marriage, diabetes care tips, the 16-day anti–gender-violence campaign, native title and land rights and other topics. SBS Nepali is a part of SBS South Asian, the destination channel for all South Asians living in Australia. To hear more audio content from SBS Nepali, subscribe to our podcast on any platform, including Apple Podcasts, YouTube Podcasts, and Spotify. SBS Nepali broadcasts a radio program every Tuesday and Thursday at 2 PM on SBS South Asian digital radio and channel 305 on your TV, live from our studios in Sydney and Melbourne. Repeats of these shows are aired every Thursday and Sunday at 4 PM on SBS Radio 2. Every Monday, listen to one full hour of contemporary Nepali songs on SBS South Asian at 2 PM. - हाम्रो पछिल्लो रेडियो कार्यक्रम सुन्नुभयो? मङ्गलवार, २ डिसेम्बर सन् २०२५ दिउँसो २ बजे एसबीएस साउथ एसियनमा प्रत्यक्ष प्रसारण भएको एसबीएस नेपालीको कार्यक्रममा हामीले पछिल्लो एक हप्ताका अस्ट्रेलियन समाचार, प्रधानमन्त्री एन्थोनी अल्बानिजीको विवाह, मधुमेह रोगको लक्षण र उपचार, नेटिभ टाइटलको वास्तविक अर्थ, नेपाल समाचार लगायत विभिन्न विषयहरू जोडेका छौँ। हाम्रो रेडियो कार्यक्रम हरेक मङ्गलवार र बिहीवार दिउँसो दुई बजे SBS South Asian मा प्रत्यक्ष प्रसारण हुन्छ। यी रेडियो कार्यक्रम बिहीवार र आइतवार SBS Radio 2 मा अपराह्न ४ देखि ५ बजेसम्म पुन प्रसारण हुन्छन्। डिजिटल रेडियोमा SBS South Asian, डिजिटल टिभीको च्यानल 305 मा अथवा SBS Audio App डाउनलोड गरेर पनि श्रोताहरूले यी कार्यक्रम सुन्न सक्नुहुन्छ। यसै गरी SBS on Demand मा गएर वा हाम्रो वेबसाइट sbs.com.au/nepali मार्फत पनि हाम्रो प्रत्यक्ष प्रसारण सुन्न सकिन्छ।

Dr. Michael Snyder joins Dr. Forbes to discuss research showing that Type 2 diabetes represents multiple metabolic subtypes rather than a single condition. He explains how glucose curve patterns, oral glucose tolerance testing, and continuous monitoring can help identify differences in muscle insulin resistance, beta-cell function, hepatic signaling, and incretin response. The conversation explores how these physiological patterns may guide individualized nutrition strategies, medication selection, and earlier detection in people with emerging dysregulation. 

In this episode of Sg2 Perspectives, host Jayme Zage, PhD is joined by Sg2 experts Emily Fitt and Rhae Ana Gamber to discuss evolving diabetes care trends through both clinical and strategic lens. They explore key differences in managing pediatric vs adult populations and type 1 vs type 2 diabetes, along with emerging innovations such as GLP-1 medications, continuous glucose monitors and automated insulin delivery systems. The conversation also highlights the importance of personalized care, social determinants of health, and systemwide planning to meet rising demand and improve outcomes.   Sg2 Perspectives Listener Feedback Survey: We would love to hear from you - Please click here   We are always excited to get ideas and feedback from our listeners. You can reach us at sg2perspectives@sg2.com, or visit the Sg2 company page on LinkedIn.

Brooke Green, NP, is a nurse practitioner at Hamilton Diabetes and Endocrinology Center. For more information about Hamilton Diabetes and Endocrinology Center call 706-278-1622 or visit www.VitruvianHealth.com/diabetes. This program in no way seeks to diagnose or treat illness or to replace professional medical care. Please see your healthcare provider if you have a health problem.

This issue will review: 1.     Screening Natriuretic Peptide Levels Predict Heart Failure and Mortality in Individuals with Type 1 and Type 2 Diabetes without Known Heart Failure 2.     The Risk of Acute Pancreatitis and Biliary Events After Initiation of Incretin-Based Medications In Patients with Type 2 Diabetes 3.     Continuous Glucose Monitoring Frequency and Glycemic Control in People With Type 2 Diabetes – JAMA Network Open  4.     An AI-Powered Lifestyle Intervention vs Human Coaching in the Diabetes Prevention Program A Randomized Clinical Trial 5.     Two-tier screening approach for liver fibrosis stratification in outpatients with type 2 diabetes mellitus: A multicenter cross-sectional study 6.     Change in urine albumin-to-creatinine ratio and clinical outcomes in patients with chronic kidney disease and type 2 diabetes   Diabetes Core Update is a monthly podcast that presents and discusses the latest clinically relevant articles from the American Diabetes Association's four science and medical journals – Diabetes, Diabetes Care, Clinical Diabetes, and Diabetes Spectrum. Each episode is approximately 25 minutes long and presents 5-6 recently published articles from ADA journals. Intended for practicing physicians and health care professionals, Diabetes Core Update   discusses how the latest research and information published in journals of the American Diabetes Association are relevant to clinical practice and can be applied in a treatment setting. For more information about each of ADA's science and medical journals, please visit Diabetesjournals.org. Hosts: Neil Skolnik, M.D., Professor of Family and Community Medicine, Sidney Kimmel Medical College, Thomas Jefferson University; Associate Director, Family Medicine Residency Program, Abington Jefferson Health John J. Russell, M.D., Professor of Family and Community Medicine, Sidney Kimmel Medical College, Thomas Jefferson University; Chair-Department of Family Medicine, Abington Jefferson Health

On this accredited episode of NP Pulse: The Voice of the Nurse Practitioner®️, expert faculty Drs. Korey Hood and Kathryn Evans-Kreider explore the psychosocial challenges of living with type 1 diabetes, with a focus on how nurse practitioners can support patients experiencing diabetes distress. Faculty discuss practical strategies, such as using brief screening tools, adopting person-first and strengths-based language and tailoring care through shared decision-making. The conversation also highlights the impact of SDOH and the importance of integrating mental health awareness into routine diabetes management. This podcast is part of the Clinical Advantage Bootcamp: Type 1 Diabetes Management Certificate for Nurse Practitioners. Visit the AANP CE Center to view the other modules. A participation code will be provided at the end of the podcast — make sure to write this code down. Once you have listened to the podcast and have the participation code, return to this activity in the AANP CE Center. Click on the "Next Steps" button of the activity and: 1. Enter the participation code that was provided. 2. Complete the posttest. 3. Complete the activity evaluation. This will award your continuing education (CE) credit and certificate of completion. 1.0 CE will be available through Nov. 30, 2027.   Tool link : Diabetes_Billing_and_Coding_Toolkit.pdf   This collaboration between AANP and Danatech, an Association of Diabetes Care and Education Specialists (ADCES) initiative, is made possible thanks to grants from Helmsley Charitable Trust, Abbott and Medtronic.

Researchers from Virginia Tech have discovered that ultra-processed meats and beverages are the worst for brain health. Individuals who consumed one or more extra servings of either of these foods showed a significantly increased risk of developing cognitive impairments, including those associated with forms of dementia such as Alzheimer's Disease. A recent article from Children's Health Defense shared new research ranking which junk foods are most harmful to the brain — and it's not just about kids' waistlines or sugar highs. It's about how what we eat can shape how we think, learn, and even feel. Let's dig into what this new research is saying, and more importantly, what it means for our families. How Junk Food Impacts the Brain These studies found that foods loaded with refined sugar, unhealthy fats, and artificial ingredients don't just harm the body — they change how the brain functions. Think of it like this: the brain runs on clear signals, kind of like a radio station. When it's getting clean fuel — whole foods, real nutrients — that signal is clear. But when it's constantly fed ultra-processed foods, it's like turning up the static. The brain starts to lose focus, memory gets fuzzy, and mood and motivation can shift. Ultra-Processed Foods (UPFs) are now known to include obesity, type 2 diabetes, cardiovascular diseases, anxiety, depression, and an increase in all-cause mortality. In fact, according to a study published in Diabetes Care, a journal of the American Diabetes Association, up to 220,000 young Americans under age 20 are likely to have Type 2 diabetes by 2060 — a 673% increase from 2017 levels. One of the studies found that people who ate a lot of processed meats, fried snacks, and sugary drinks had measurable changes in the areas of the brain that control memory and emotion. Another study showed that even short-term diets high in sugar and fat can rewire how the brain's “reward center” works — making people crave those same foods even more. A study of nearly 124,000 people found that drinking just one daily serving of artificially sweetened drinks increased the risk of a liver disease known as nonalcoholic fatty liver disease or metabolic dysfunction. That means the more we eat these foods, the more our brains want them, creating a loop that's hard to break. Why Kids Are Especially Affected Recent research has shed light on a startling concern—more than 300 chemicals have been detected in babies' cord blood and placenta at birth. This discovery highlights the fact that exposure to harmful chemicals begins much earlier than we previously thought. From conception through pregnancy, toxins can pass from the mother to the fetus, raising concerns about their potential long-term effects on child development and health. Children's brains are still developing, which makes them much more sensitive to these kinds of foods. When a growing brain is constantly exposed to sugary, processed foods, it can interfere with how nerve connections form. Some of the research cited by Children's Health Defense found that kids and teens who eat a lot of junk food have more trouble with memory and learning, and can experience more mood swings or attention issues. Part of that is because junk foods crowd out the nutrients that developing brains need — like omega-3s, zinc, and iron. And part of it is chemical: those processed ingredients can actually change the way the brain's reward systems respond, which makes healthy foods less appealing over time... Click Here or Click the link below for more details! https://naturallyrecoveringautism.com/233

StartUp Health community member Katharine Barnard-Kelly, PhD, CEO & Co-founder of Spotlight-AQ, joins StartUp Health co-founder Unity Stoakes to share how her team is transforming diabetes care by giving providers a window into their patients' real lives. In this inspiring conversation, Dr. Barnard-Kelly explains how Spotlight-AQ's AI-driven clinical tool helps providers deliver holistic, biopsychosocial care that improves outcomes for patients, reduces burnout for clinicians, and saves costs for health systems. In this episode: How Spotlight-AQ uses AI to match each patient's real-world experience with optimal routine care The simple, three-minute questionnaire that helps providers focus on what matters most Why holistic care is critical for managing chronic conditions like diabetes and obesity Lessons from Dr. Barnard-Kelly's journey from health psychology to health tech entrepreneurship How Spotlight-AQ achieved FDA qualification for a person-reported outcome measure in diabetes What's next after earning second place in the 2025 Breakthrough T1D Israel Innovation Challenge Why being part of the StartUp Health community has been so valuable for connection and collaboration Tune in to hear how Dr. Katharine Barnard-Kelly is building a bridge between science and clinical practice – and making biopsychosocial care the new standard for precision medicine. Are you ready to tell YOUR story? Members of our Health Moonshot Communities are leading startups with breakthrough technology-driven solutions for the world's biggest health challenges. Exposure in StartUp Health Media to our global audience of investors and partners – including our podcast, newsletters, magazine, and YouTube channel – is a benefit of our Health Moonshot PRO Membership. To schedule a call and see if you qualify to join and increase brand awareness through our multi-media storytelling efforts, submit our three-minute application. If you're mission-driven, collaborative, and ready to contribute as much as you gain, you might be the perfect fit. » Learn more and apply today. Want more content like this? Sign up for StartUp Health Insider™ to get funding insights, news, and special updates delivered to your inbox.

In this special episode on a Beta Cell Update Dr. Neil Skolnik discusses this emerging area with Dr. Melena Bellin. This special episode is supported by an independent educational grant from Sanofi. Presented by: Neil Skolnik, M.D., Professor of Family and Community Medicine, Sidney Kimmel Medical College, Thomas Jefferson University; Associate Director, Family Medicine Residency Program, Abington Jefferson Health Melena Bellin.  Professor, Pediatric Endocrinology, and Surgery, Co-Director, Total Pancreatectomy and Islet Autotransplant Program and the Albert D. and Eva J. Corniea Chair, University of Minnesota/ Masonic Children's Hospital      Selected References: Consensus guidance for monitoring individuals with islet autoantibody-positive pre-stage 3 type 1 diabetes. Diabetes Care 2024;47(8):1276–1298 An Anti-CD3 Antibody, Teplizumab, in Relatives at Risk for Type 1 Diabetes. N Engl J Med 2019;381:603-613 Management of Latent Autoimmune Diabetes in Adults: A Consensus Statement . Diabetes 2020;69(10):2037–2047 Resources for Auto-antibody Testing: Type 1 Diabetes TrialNet Centers of Excellence Locations Type 1 Risk test         Trialnet  

In this episode of The Huddle, Janice Baker, MBA, RDN, CDCES, CNSC, BC-ADM, joins Julia Socke, RDN, LDN, CDCES, for an insightful conversation on common nutrition myths and the importance of holistic diabetes care. Drawing on nearly 43 years of experience, Janice shares her evidence-based perspectives on topics like low-carb diets, artificial sweeteners, and protein. She also discusses her collaborative approach to working with other healthcare providers and highlights often-overlooked aspects of diabetes management—such as foot and dental care—that contribute to truly comprehensive patient support. Join us for an enlightening discussion that blends clinical expertise with practical strategies for whole-person diabetes care. Listen to more episodes of The Huddle at adces.org/perspectives/the-huddle-podcast.Learn more about ADCES and the many benefits of membership at adces.org/join. Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.

This issue will review: 1.     Effects of Semaglutide With or Without Concomitant Mineralocorticoid Receptor Antagonist Use in Participants With Type 2 Diabetes and Chronic Kidney Disease: A FLOW Trial Prespecified Secondary Analysis  - Diabetes Care 2.     Orforglipron, an Oral Small-Molecule GLP-1Receptor Agonist, in Early Type 2 Diabetes – NEJM 3.     Orforglipron, an Oral Small-Molecule GLP-1 Receptor Agonist for Obesity Treatment – NEJM 4.     Dementia Risk in People With Type 1 Diabetes and Associated Risk Factors – Diabetes Care 5.     Impact of baseline GLP-1 Receptor Agonist Use on Albuminuria Reduction and Safety With Simultaneous Initiation of Finerenone and Empagliflozin in Type 2 Diabetes and CKD – Diabetes Care 6.     Oral Semaglutide at a Dose of 25 mg in Adults with Overweight or Obesity -  NEJM    Diabetes Core Update is a monthly podcast that presents and discusses the latest clinically relevant articles from the American Diabetes Association's four science and medical journals – Diabetes, Diabetes Care, Clinical Diabetes, and Diabetes Spectrum. Each episode is approximately 25 minutes long and presents 5-6 recently published articles from ADA journals. Intended for practicing physicians and health care professionals, Diabetes Core Update   discusses how the latest research and information published in journals of the American Diabetes Association are relevant to clinical practice and can be applied in a treatment setting. For more information about each of ADA's science and medical journals, please visit Diabetesjournals.org. Hosts: Neil Skolnik, M.D., Professor of Family and Community Medicine, Sidney Kimmel Medical College, Thomas Jefferson University; Associate Director, Family Medicine Residency Program, Abington Jefferson Health John J. Russell, M.D., Professor of Family and Community Medicine, Sidney Kimmel Medical College, Thomas Jefferson University; Chair-Department of Family Medicine, Abington Jefferson Health

Until recently, Jeremy Auger's diabetes was unstable. Then he met endocrinologist Dr. David Campbell and the team with the diabetes mobile clinic in Calgary. The roving clinic brings care directly to people who are homeless or have low incomes. For patients like Jeremy, it's a lifeline that helps prevent devastating complications.

Kent Schnakenberg returns to share how one bike ride turned into a life's mission—raising awareness, saving lives, and inspiring thousands through Team Snack Strong and the fight against type 1 diabetes. Go tubeless with Omnipod 5 or Omnipod DASH * Dexcom G7 CONTOUR NextGen smart meter and CONTOUR DIABETES app Get your supplies from US MED or call 888-721-1514 Tandem Mobi twiist AID System Free Juicebox Community (non Facebook) Type 1 Diabetes Pro Tips - THE PODCAST Eversense CGM Medtronic Diabetes Drink AG1.com/Juicebox Touched By Type 1 Take the T1DExchange survey Use code JUICEBOX to save 40% at Cozy Earth Apple Podcasts> Subscribe to the podcast today! The podcast is available on Spotify, Google Play, iHeartRadio, Radio Public, Amazon Music and all Android devices The Juicebox Podcast is a free show, but if you'd like to support the podcast directly, you can make a gift here or buy me a coffee. Thank you! The Pod has an IP28 rating for up to 25 feet for 60 minutes. The PDM is not waterproof. Brown et al. Diabetes Care (2021). Sherr et al. Diabetes Care (2022). Pasquel FJ, et al. JAMA Network Open (2025). Single-arm studies comparing 3 months of Omnipod 5 use to standard therapy in 240 people aged 6-70 years and 80 people aged 2-5.9 years with type 1 diabetes and 305 people aged 18-75 years with type 2 diabetes. Disclaimer - Nothing you hear on the Juicebox Podcast or read on Arden's Day is intended as medical advice. You should always consult a physician before making changes to your health plan. If the podcast has helped you to live better with type 1 please tell someone else how to find it!

Hey Diabuddy thank you for listening to show, send me some positive vibes with your favorite part of this episode.In this episode, I sit down once again with returning guest and college athlete Jaci Carpenter for an honest conversation about the realities of navigating diabetes care as a young adult. From frustrating endocrinology visits and inflated medical costs to learning how to advocate for yourself and manage nutrition beyond “just taking insulin for what you eat,” this episode shines a light on what so many people with diabetes face every day.Our Deep Dive Includes:Why Jaci's recent endocrinology experience left her classified as a “high-risk diabetic” — and what that really meansHow the healthcare and insurance systems often fail those who are doing everything rightThe emotional and financial weight of affording insulin, CGMs, and pump suppliesLearning to question outdated medical advice and advocate for your own careThe difference between textbook diabetes management and real-life diabetes management as an athleteWhy nutrition is more than carb counting — and how to make food choices that support long-term health and stabilityFinding balance between discipline, mental health, and living your life freely with diabetes

Scott talks with Marley, mom to one-year-old Bane, diagnosed after DKA and a life flight. From ICU to CGM and Mobi, she shares hard-won reality, faith, and growing TikTok advocacy. Go tubeless with Omnipod 5 or Omnipod DASH * Dexcom G7 CONTOUR NextGen smart meter and CONTOUR DIABETES app Get your supplies from US MED  or call 888-721-1514 Tandem Mobi  twiist AID System Free Juicebox Community (non Facebook) Type 1 Diabetes Pro Tips - THE PODCAST Eversense CGM Medtronic Diabetes Drink AG1.com/Juicebox Touched By Type 1 Take the T1DExchange survey Use code JUICEBOX to save 40% at Cozy Earth  Apple Podcasts> Subscribe to the podcast today! The podcast is available on Spotify, Google Play, iHeartRadio, Radio Public, Amazon Music and all Android devices The Juicebox Podcast is a free show, but if you'd like to support the podcast directly, you can make a gift here or buy me a coffee. Thank you! The Pod has an IP28 rating for up to 25 feet for 60 minutes. The PDM is not waterproof. Brown et al. Diabetes Care (2021). Sherr et al. Diabetes Care (2022). Pasquel FJ, et al. JAMA Network Open (2025). Single-arm studies comparing 3 months of Omnipod 5 use to standard therapy in 240 people aged 6-70 years and 80 people aged 2-5.9 years with type 1 diabetes and 305 people aged 18-75 years with type 2 diabetes. Disclaimer - Nothing you hear on the Juicebox Podcast or read on Arden's Day is intended as medical advice. You should always consult a physician before making changes to your health plan.  If the podcast has helped you to live better with type 1 please tell someone else how to find it!

Join Dr. Cecilia Lansang, Associate Editor of Endocrine Practice, Professor of Medicine, and Director of Endocrinology at Cleveland Clinic, as she speaks with Dr. Kristen Flint, Interim Director of Quality and Safety for Endocrinology at Massachusetts General Hospital, Attending Endocrinologist at MGH, and Instructor at Harvard Medical School, about her team's quality improvement project, “Expanding Access to Continuous Glucose Monitoring in Medicare Patients Receiving Specialty Diabetes Care.” This episode covers:Strategies for implementing quality improvement interventions in a large academic diabetes specialty clinicKey interventions that increased CGM utilization, including targeted provider education, workflow optimization, and patient outreachLessons for advancing equitable implementation and sustaining quality improvement over time Tune in for practical insights on bridging policy changes and clinical practice to improve CGM access for Medicare patients. Read the full article in the August 2025 issue of Endocrine Practice here.

Katharyne, 47, was diagnosed with type 1 diabetes at the start of 2025 and is still in her honeymoon phase. Go tubeless with Omnipod 5 or Omnipod DASH * Dexcom G7 CONTOUR NextGen smart meter and CONTOUR DIABETES app Get your supplies from US MED  or call 888-721-1514 Tandem Mobi  twiist AID System Free Juicebox Community (non Facebook) Type 1 Diabetes Pro Tips - THE PODCAST Eversense CGM Medtronic Diabetes Drink AG1.com/Juicebox Touched By Type 1 Take the T1DExchange survey Use code JUICEBOX to save 40% at Cozy Earth  Apple Podcasts> Subscribe to the podcast today! The podcast is available on Spotify, Google Play, iHeartRadio, Radio Public, Amazon Music and all Android devices The Juicebox Podcast is a free show, but if you'd like to support the podcast directly, you can make a gift here or buy me a coffee. Thank you! The Pod has an IP28 rating for up to 25 feet for 60 minutes. The PDM is not waterproof. Brown et al. Diabetes Care (2021). Sherr et al. Diabetes Care (2022). Pasquel FJ, et al. JAMA Network Open (2025). Single-arm studies comparing 3 months of Omnipod 5 use to standard therapy in 240 people aged 6-70 years and 80 people aged 2-5.9 years with type 1 diabetes and 305 people aged 18-75 years with type 2 diabetes. Disclaimer - Nothing you hear on the Juicebox Podcast or read on Arden's Day is intended as medical advice. You should always consult a physician before making changes to your health plan.  If the podcast has helped you to live better with type 1 please tell someone else how to find it!  

Jenny and Scott talk about bolusing for CTC. Go tubeless with Omnipod 5 or Omnipod DASH * Dexcom G7 CONTOUR NextGen smart meter and CONTOUR DIABETES app Get your supplies from US MED  or call 888-721-1514 Tandem Mobi  twiist AID System Free Juicebox Community (non Facebook) Type 1 Diabetes Pro Tips - THE PODCAST Eversense CGM Medtronic Diabetes Drink AG1.com/Juicebox Touched By Type 1 Take the T1DExchange survey Use code JUICEBOX to save 40% at Cozy Earth  Apple Podcasts> Subscribe to the podcast today! The podcast is available on Spotify, Google Play, iHeartRadio, Radio Public, Amazon Music and all Android devices The Juicebox Podcast is a free show, but if you'd like to support the podcast directly, you can make a gift here or buy me a coffee. Thank you! The Pod has an IP28 rating for up to 25 feet for 60 minutes. The PDM is not waterproof. Brown et al. Diabetes Care (2021). Sherr et al. Diabetes Care (2022). Pasquel FJ, et al. JAMA Network Open (2025). Single-arm studies comparing 3 months of Omnipod 5 use to standard therapy in 240 people aged 6-70 years and 80 people aged 2-5.9 years with type 1 diabetes and 305 people aged 18-75 years with type 2 diabetes. Disclaimer - Nothing you hear on the Juicebox Podcast or read on Arden's Day is intended as medical advice. You should always consult a physician before making changes to your health plan.  If the podcast has helped you to live better with type 1 please tell someone else how to find it!

Physician Daryna Bahriy discusses her article "How Ukrainian doctors kept diabetes care alive during the war," sharing how medical teams in western Ukraine adapted to protect vulnerable patients amid the chaos of conflict. Daryna explains how disrupted supply chains threatened insulin access, how doctors rapidly coordinated resource redistribution, and how patient education initiatives provided life-saving guidance in bomb shelters. She reflects on the importance of leadership, foresight, and humanity in medicine during crisis. Listeners will learn how health systems can prepare for instability, support chronic disease patients under extraordinary conditions, and draw strength from resilience and solidarity. Our presenting sponsor is Microsoft Dragon Copilot. Microsoft Dragon Copilot, your AI assistant for clinical workflow, is transforming how clinicians work. Now you can streamline and customize documentation, surface information right at the point of care, and automate tasks with just a click. Part of Microsoft Cloud for Healthcare, Dragon Copilot offers an extensible AI workspace and a single, integrated platform to help unlock new levels of efficiency. Plus, it's backed by a proven track record and decades of clinical expertise—and it's built on a foundation of trust. It's time to ease your administrative burdens and stay focused on what matters most with Dragon Copilot, your AI assistant for clinical workflow. VISIT SPONSOR → https://aka.ms/kevinmd SUBSCRIBE TO THE PODCAST → https://www.kevinmd.com/podcast RECOMMENDED BY KEVINMD → https://www.kevinmd.com/recommended

Laura, 55, was diagnosed with type 1 in March 2024 after months of missed signs, DKA, septic shock, and necrotizing fasciitis. Now on a GLP, she's honeymooning without insulin. Part 1 of 2 Go tubeless with Omnipod 5 or Omnipod DASH * Dexcom G7 CONTOUR NextGen smart meter and CONTOUR DIABETES app Get your supplies from US MED  or call 888-721-1514 Tandem Mobi  twiist AID System Free Juicebox Community (non Facebook) Type 1 Diabetes Pro Tips - THE PODCAST Eversense CGM Medtronic Diabetes Drink AG1.com/Juicebox Touched By Type 1 Take the T1DExchange survey Use code JUICEBOX to save 40% at Cozy Earth  Apple Podcasts> Subscribe to the podcast today! The podcast is available on Spotify, Google Play, iHeartRadio, Radio Public, Amazon Music and all Android devices The Juicebox Podcast is a free show, but if you'd like to support the podcast directly, you can make a gift here or buy me a coffee. Thank you! The Pod has an IP28 rating for up to 25 feet for 60 minutes. The PDM is not waterproof. Brown et al. Diabetes Care (2021). Sherr et al. Diabetes Care (2022). Pasquel FJ, et al. JAMA Network Open (2025). Single-arm studies comparing 3 months of Omnipod 5 use to standard therapy in 240 people aged 6-70 years and 80 people aged 2-5.9 years with type 1 diabetes and 305 people aged 18-75 years with type 2 diabetes. Disclaimer - Nothing you hear on the Juicebox Podcast or read on Arden's Day is intended as medical advice. You should always consult a physician before making changes to your health plan.  If the podcast has helped you to live better with type 1 please tell someone else how to find it!  

Megan, 36, has lived with T1D since age 4 and now faces lupus too. Go tubeless with Omnipod 5 or Omnipod DASH * Dexcom G7 CONTOUR NextGen smart meter and CONTOUR DIABETES app Get your supplies from US MED  or call 888-721-1514 Tandem Mobi  twiist AID System Free Juicebox Community (non Facebook) Type 1 Diabetes Pro Tips - THE PODCAST Juice Cruise 2026 - Come Sail Away Eversense CGM Medtronic Diabetes Drink AG1.com/Juicebox Touched By Type 1 Take the T1DExchange survey Use code JUICEBOX to save 40% at Cozy Earth  Apple Podcasts> Subscribe to the podcast today! The podcast is available on Spotify, Google Play, iHeartRadio, Radio Public, Amazon Music and all Android devices The Juicebox Podcast is a free show, but if you'd like to support the podcast directly, you can make a gift here or buy me a coffee. Thank you! The Pod has an IP28 rating for up to 25 feet for 60 minutes. The PDM is not waterproof. Brown et al. Diabetes Care (2021). Sherr et al. Diabetes Care (2022). Pasquel FJ, et al. JAMA Network Open (2025). Single-arm studies comparing 3 months of Omnipod 5 use to standard therapy in 240 people aged 6-70 years and 80 people aged 2-5.9 years with type 1 diabetes and 305 people aged 18-75 years with type 2 diabetes. Disclaimer - Nothing you hear on the Juicebox Podcast or read on Arden's Day is intended as medical advice. You should always consult a physician before making changes to your health plan.  If the podcast has helped you to live better with type 1 please tell someone else how to find it!  

Elle spent years hiding her diabetes, surviving burnout, and even a coma. Now she's leaning in, healing old wounds, and building community through honesty and connection. Go tubeless with Omnipod 5 or Omnipod DASH * Dexcom G7 CONTOUR NextGen smart meter and CONTOUR DIABETES app Get your supplies from US MED  or call 888-721-1514 Tandem Mobi  twiist AID System Free Juicebox Community (non Facebook) Type 1 Diabetes Pro Tips - THE PODCAST Juice Cruise 2026 - Come Sail Away Eversense CGM Medtronic Diabetes Drink AG1.com/Juicebox Touched By Type 1 Take the T1DExchange survey Use code JUICEBOX to save 40% at Cozy Earth  Apple Podcasts> Subscribe to the podcast today! The podcast is available on Spotify, Google Play, iHeartRadio, Radio Public, Amazon Music and all Android devices The Juicebox Podcast is a free show, but if you'd like to support the podcast directly, you can make a gift here or buy me a coffee. Thank you! The Pod has an IP28 rating for up to 25 feet for 60 minutes. The PDM is not waterproof. Brown et al. Diabetes Care (2021). Sherr et al. Diabetes Care (2022). Pasquel FJ, et al. JAMA Network Open (2025). Single-arm studies comparing 3 months of Omnipod 5 use to standard therapy in 240 people aged 6-70 years and 80 people aged 2-5.9 years with type 1 diabetes and 305 people aged 18-75 years with type 2 diabetes. Disclaimer - Nothing you hear on the Juicebox Podcast or read on Arden's Day is intended as medical advice. You should always consult a physician before making changes to your health plan.  If the podcast has helped you to live better with type 1 please tell someone else how to find it!